Immunotoxin therapy of cancer

Ira Pastan; Raffit Hassan; David J. FitzGerald; Robert J. Kreitman

doi:10.1038/nrc1891

Keywords

ImmunotoxinAntibodyRecombinant DNAAntigenImmunotherapyCancerCancer researchCytotoxic T cellClinical trialMedicineImmunologyMonoclonal antibodyIn vitroChemistryBiochemistryInternal medicineGene

Affiliated Institutions

MRC Laboratory of Molecular Biology GB

Related Publications

Immunotoxin Conjugation Techniques

Greg T. Hermanson

1996 Elsevier eBooks 90 citations

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

F. Stephen Hodi , Martín C. Mihm , Robert J. Soiffer +14 more

A large number of cancer-associated gene products evoke immune recognition, but host reactions rarely impede disease progression. The weak immunogenicity of nascent tumors contr...

2003 Proceedings of the National Academy o... 990 citations

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin , Xiuli Zhang , Heiko Schuster +24 more

The immune system influences the fate of developing cancers by not only functioning as a tumour promoter that facilitates cellular transformation, promotes tumour growth and scu...

2014 Nature 1936 citations

T cells that help B cell responses to soluble antigen are distinguishable from those producing interleukin 2 on mitogenic or allogeneic stimulation.

Robert Arthur , Don Mason

An mAb MRC OX-22, reactive with the high molecular weight forms of the rat leukocyte-common antigen, has revealed a heterogeneity among CD4+ T cells in this species. Approximate...

1986 The Journal of Experimental Medicine 214 citations

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

F. Stephen Hodi , Marcus O. Butler , Darryl A. Oble +17 more

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) functions as a negative regulator of endogenous and vaccine-induced antitumor immunity. The administration of fully human an...

2008 Proceedings of the National Academy o... 649 citations

Publication Info

Year: 2006
Type: review
Volume: 6
Issue: 7
Pages: 559-565
Citations: 515
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Immunotoxin therapy of cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

515

OpenAlex

Cite This

APA Style

                            
                                
                                    Ira Pastan, 
                                
                                    Raffit Hassan, 
                                
                                    David J. FitzGerald
                                
                                et al.
                            
                            (2006). 
                            Immunotoxin therapy of cancer. 
                            Nature reviews. Cancer
                            , 6
                            (7)
                            , 559-565.
                            https://doi.org/10.1038/nrc1891
                        

Identifiers

DOI: 10.1038/nrc1891